Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous paracetamol versus ibuprofen for patent ductus arteriosus in preterm neonates
IRCT20190824044600N1Phase 3Completed
- Sponsor
- Ardabil University of Medical Sciences
- Start
- Sep 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of acetaminophen and ibuprofen in patent ductus arteriosus (PDA) (2 arms), sponsored by Ardabil University of Medical Sciences. Primary endpoints: Time for PDA treatment, Effect on liver markers and 1 more. Started Sep 2018; status: completed.
02
Drugs
acetaminophenibuprofen
03
Conditions
patent ductus arteriosus (PDA)
Beyond the preview
Go deeper on IRCT20190824044600N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190824044600N1.